Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-22
DOI
10.1038/srep17559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The serpin PN1 is a feedback regulator of FGF signaling in germ layer and primary axis formation
- (2015) H. Acosta et al. DEVELOPMENT
- Proprotein Convertase Subtilisin/Kexin Type 9 Deficiency Reduces Melanoma Metastasis in Liver
- (2015) Xiaowei Sun et al. NEOPLASIA
- Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation
- (2014) Amy Flick et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- PCSK9 is Present in Human Cerebrospinal Fluid and is Maintained at Remarkably Constant Concentrations Throughout the Course of the Day
- (2014) Yan Q. Chen et al. LIPIDS
- SELDI-TOF-MS Proteomic Profiling of Serum, Urine, and Amniotic Fluid in Neural Tube Defects
- (2014) Zhenjiang Liu et al. PLoS One
- Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
- (2013) Nabil G. Seidah CURRENT PHARMACEUTICAL DESIGN
- Integrated Proteomics Pipeline Yields Novel Biomarkers for Predicting Preeclampsia
- (2013) Jenny E. Myers et al. HYPERTENSION
- Papers from the 7th International Neural Tube Defects Conference
- (2012) Anne M. Molloy et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects
- (2012) Hui Gu et al. JOURNAL OF NEUROCHEMISTRY
- Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11–13 Weeks?
- (2011) Anna Lucia Mastricci et al. FETAL DIAGNOSIS AND THERAPY
- PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke
- (2011) Estelle Rousselet et al. JOURNAL OF LIPID RESEARCH
- Comparative proteomics of spinal cords of rat fetuses with spina bifida aperta
- (2011) Yang Fan et al. Journal of Proteomics
- Proteomic analysis of amniotic fluid of pregnant rats with spina bifida aperta
- (2011) Liping Shan et al. Journal of Proteomics
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology
- (2010) Jana Auer et al. Journal of Proteomics
- Proteomics and Down syndrome screening: a validation study
- (2010) M. P. H. Koster et al. PRENATAL DIAGNOSIS
- The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry
- (2009) Hong-juan Song et al. ACTA PHARMACOLOGICA SINICA
- Proteomic Approaches to Cancer Biomarkers
- (2009) Kenneth E. Hung et al. GASTROENTEROLOGY
- Prenatal screening and diagnosis of neural tube defects
- (2009) Martin Cameron et al. PRENATAL DIAGNOSIS
- PCSK9 as a therapeutic target of dyslipidemia
- (2008) Nabil G Seidah EXPERT OPINION ON THERAPEUTIC TARGETS
- Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?
- (2008) Naveen S. Vasudev et al. PROTEOMICS
- Placental Pathology: A Systematic Approach with Clinical Correlations
- (2007) R.W. Redline PLACENTA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started